The +3187A/G HLA-G polymorphic site is associated with polar forms and reactive reaction in leprosy

Molecular Genetics and Genomic Medicine

Volumn 1, Issue 3, 2013, Pages 123-130

  Lucena Silva, N ^a,b,c   Teixeira, M A G ^d   Ramos, A de L ^b   de Albuquerque, R S ^a,c   Diniz, G T N ^a   Mendes Junior, C T ^c   Castelli, E C ^e   Donadi, E A ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^e FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

3 UTR polymorphism; Hansenic reaction; HLA G; Leprosy

Indexed keywords

EID: 84971641144     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.14     Document Type: Article

References (38)

1. Aggarwal, S., S. Ali, R. Chopra, A. Srivastava, P. Kalaiarasan, D. Malhotra, et al. 2011. Genetic variations and interactionsin anti-inflammatory cytokine pathway genes in theoutcome of leprosy: a study conducted on a MassARRAYplatform. J. Infect. Dis. 204:1264–1273.
2. Alvarado-Navarro, A., M. Montoya-Buelna, J. F. Muñoz-Valle, R. I. López-Roa, C. Guillén-Vargas, and M. Fafutis-Morris. 2008. The 3’UTR 1188 A/C polymorphism in theinterleukin-12p40 gene (IL-12B) is associated withlepromatous leprosy in the west of Mexico. Immunol. Lett.118:148–151.
3. Attia, E. A., M. Abdallah, A. A. Saad, A. Afifi, A. El Tabbakh, D. El-Shennawy, et al. 2010. Circulating CD4+ CD25 highFoxP3+ T cells vary in different clinical forms of leprosy. Int. J. Dermatol. 49:1152–1158.
4. Berrington, W. R., M. Macdonald, S. Khadge, B. R. Sapkota, M. Janer, D. A. Hagge, et al. 2010. Common polymorphismsin the NOD2 gene region are associated with leprosy and itsreactive states. J. Infect. Dis. 201:1422–1435.
5. Bulletin of Brazilian Health Ministry. 2010. Boletim Trimestralde Hanseníase. Secretaria de Saúde, Diretoria de Vigilância á Saúde do Estado de Pernambuco, Pernambuco. Referenceperiod: 3 January 2010 to 31 December 2010. Published in31 January 2011.
6. Cardoso, C. C., A. C. Pereira, V. N. Brito-de-Souza, S. M. Duraes, M. Ribeiro-Alves, J. A. Nery, et al. 2011. TNF-308G>A single nucleotide polymorphism is associated withleprosy among Brazilians: a genetic epidemiology assessment, meta-analysis, and functional study. J. Infect. Dis. 204:1256–1263.
7. Carosella, E. D., K. Y. HoWangYin, B. Favier, and J. LeMaoult.2008. HLA-G–dependent suppressor cells: diverse by nature, function, and significance. Hum. Immunol. 69:700–707.
8. Castelli, E. C., C. T. Mendes-Junior, N. H. S. Deghaide, R. S. de Albuquerque, Y. C. Muniz, R. T. Simões, et al. 2010. The genetic structure of 3′ untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun. 11:134–141.
9. Castelli, E. C., C. T. Mendes-Junior, L. C. Veiga-Castelli, M. Roger, Moreau Philippe, and E. A. Donadi. 2011. A comprehensive study of polymorphic sites along the HLA-Ggene: implication for gene regulation and evolution. Mol. Biol. Evol. 28:3069–3086.
10. Cavalcanti, A. A. L., N. Lucena-Silva, U. R. Montarroyos, and P. M. C. C. de Albuquerque. 2012. Concordance between expected and observed bacilloscopy results of clinical formsof leprosy: a 6-year retrospective study in Recife, Pernambuco State, Brazil. Rev. Soc. Bras. Med. Trop.45:616–619.
11. Cristofaro, J. D., D. E. Moujally, A. Agnel, S. Mazières, M. Cortez, A. Basire, et al. 2012. HLA-G haplotype structureshows good conservation between different populations andgood correlation with high, normal and low soluble HLA-Gexpression. Hum. Immunol. 74:203–206.
12. Cuevas, J., J. L. Rodríguez-Peralto, R. Carrillo, and F. Contreras. 2007. Erythema nodosum leprosum: reactional leprosy. Semin. Cutan. Med. Surg. 26:126–130.
13. Donadi, E. A., E. C. Castelli, A. Arnaiz-Villena, M. Roger, D. Rey, and P. Moreau. 2011. Implications of the polymorphism of HLA-G on its function, regulation,evolution and disease association. Cell. Mol. Life Sci. 68:369–395.
14. Excoffier, L., and M. Slatkin. 1995. Maximum-likelihoodestimation of molecular haplotype frequencies in a diploidpopulation. Mol. Biol. Evol. 12:921–927.
15. Excoffier, L., G. Laval, and S. Schneider. 2005. Arlequin ver.3.0: an integrated software package for population geneticsdata analysis. Evol. Bioinform. Online 1:47–50.
16. Ferguson, R., A. V. Ramanakumar, A. Koushik, F. Coutlée, E. Franco, M. Roger, and Biomarkers of Cervical Cancer Risk Study Team. 2012. Human leukocyte antigen Gpolymorphism is associated with an increased risk of invasivecancer of the uterine cervix. Int. J. Cancer 131:E312–E319.
17. Gruenheid, S., and P. Gros. 2000. Genetic susceptibility tointracellular infections: Nramp1, macrophage function anddivalent cations transport. Curr. Opin. Microbiol. 3:43–48.
18. Huang, Y. H., A. L. Zozulya, C. Weidenfeller, N. Schwab, and H. Wiendl. 2009. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells isIL-10-dependent and reversible. J. Leukoc. Biol. 86: 273–281.
19. Laal, S., L. K. Bhutani, and I. Nath. 1985. Natural emergenceof antigen-reactive T cells in lepromatous leprosy patientsduring erythema nodosum leprosum. Infect. Immun.50:887–892.
20. Larsen, M. H., S. Hylenius, A. M. Andersen, and T. V. Hviid.2010. The 3′-untranslated region of the HLA-G gene inrelation to pre-eclampsia: revisited. Tissue Antigens 75:253–261.
21. Lucena-Silva, N., A. L. Monteiro, R. S. de Albuquerque, R. G. Gomes, C. T. Mendes-Junior, E. C. Castelli, et al. 2012.Haplotype frequencies based on eight polymorphic sites atthe 3′ untranslated region of the HLA-G gene in individuals from two different geographical regions of Brazil. TissueAntigens 79:272–278.
22. de Messias-Reason, I. J., A. B. Boldt, A. C. Moraes Braga, E. Von Rosen Seeling Stahlke, L. Dornelles, L. Pereira-Ferrari, P. G. Kremsner, and J. F. Kun. 2007. Theassociation between mannan-binding lectin genepolymorphism and clinical leprosy: new insight into an oldparadigm. J. Infect. Dis. 196:1379–85.
23. Moraes, M. O., N. C. Duppre, P. N. Suffys, A. R. Santos, A. S. Almeida, J. A. Nery, et al. 2001. Tumor necrosis factor-alpha promoter polymorphism TNF2 is associatedwith a stronger delayed-type hypersensitivity reaction in theskin of borderline tuberculoid leprosy patients. Immunogenetics 53:45–47.
24. de Oca EPM. 2011. Human polymorphisms as clinicalpredictors in leprosy. J. Trop. Med. 2011:923943.
25. de Oca, E. P. M., J. S. Velarde-Félix, J. J. Ríos-Tostado, V. J. Picos-Cárdenas, and L. E. Figuera. 2009. SNP 668C(-44) alters a NF-kB1 putative binding site in non-codingstrand of human b-defensin 1 (DEFB1) and is associatedwith lepromatous leprosy. Infect. Genet. Evol. 9:617–625.
26. Roy, S., A. Frodsham, B. Saha, S. K. Hazra, C. G. Mascie-Taylor, and A. V. Hill. 1999. Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis. 179:187–191.
27. Sampaio, L. H., A. L. Sousa, M. C. Barcelos, S. G. Reed, M. M. Stefani, and M. S. Duthie. 2012. Evaluation of various cytokines elicited during antigen-specific recall aspotential risk indicators for the differential development ofleprosy. Eur. J. Clin. Microbiol. Infect. Dis. 31:1443–1451.
28. Santos, A. R., P. N. Suffys, P. R. Vanderborght, M. O. Moraes, L. M. Vieira, P. H. Cabello, et al. 2002. Role of tumor necrosis factor-alpha and interleukin-10 promotergene polymorphisms in leprosy. J. Infect. Dis. 186: 1687–1691.
29. Sapkota, B. R., M. Macdonald, W. R. Berrington, E. A. Misch, C. Ranjit, M. R. Siddiqui, et al. 2010. Association of TNF,MBL, and VDR polymorphisms with leprosy phenotypes. Hum. Immunol. 71:992–998.
30. Shankarkumar, U., K. Ghosh, S. Badakere, and D. Mohanty.2003. Novel HLA Class I Alleles Associated with IndianLeprosy Patients. J. Biomed. Biotechnol. 2003:208–211.
31. Shaw, M. A., I. J. Donaldson, A. Collins, C. S. Peacock, Z. Lins-Lainson, J. J. Shaw, et al. 2001. Association and linkage of leprosy phenotypes with HLA class II and tumournecrosis factor genes. Genes Immun. 2:196–204.
32. Stephens, M., N. J. Smith, and P. Donnelly. 2001. A newstatistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68:978–989.
33. Teixeira, M. A., N. L. Silva, A. de L. Ramos, A. Hatagima, and V. Magalhães. 2010. NRAMP1 gene polymorphisms inindividuals with leprosy reactions attended at two referencecenters in Recife, northeastern Brazil. Rev. Soc. Bras. Med. Trop. 43:281–286. Portuguese.
34. Vasconcelos, L. R., J. P. Fonseca, R. F. do Carmo, T. F. deMendonca, V. R. Pereira, N. Lucena-Silva, L. M. Pereira, P. Moura, and M. do S. Cavalcanti. 2011. Mannosebindinglectin serum levels in patients with leprosy are influenced by age and MBL2 genotypes. Int. J. Infect. Dis.15:e551–e557.
35. Walker, S. L., and D. N. J. Lockwood. 2006. The clinical andimmunological features of leprosy. Br. Med. Bull. 77–78:103–121.
36. Yang, Q., and M. J. Khoury. 1997. Evolving methods ingenetic epidemiology. III. Gene-environment interaction inepidemiologic research. Epidemiol. Rev. 19:33–43.
37. Yang, D., H. Song, W. Xu, H. Long, C. Shi, Z. Jing, et al. 2011. Interleukin 4–590T/C polymorphism andsusceptibility to leprosy. Genet. Test. Mol. Biomarkers 15:877–881.
38. Yie, S. M., L. H. Li, R. Xiao, and C. L. Librach. 2008. A singlebase-pair mutation in the 3′-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol. Hum. Reprod. 14:649–653.